Amryt receives reimbursement approval from NICE for Myalepta as an adjunct to diet as replacement therapy for the treatment of leptin deficiency.

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest